TYPE1DIABETES
Clinical trials for TYPE1DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE1DIABETES trials appear
Sign up with your email to follow new studies for TYPE1DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Probiotic shows promise in slowing type 1 diabetes progression
Disease control OngoingThis study tests whether a probiotic called Lactiplantibacillus plantarum 299v can reduce inflammation and help preserve the body's ability to produce insulin in people recently diagnosed with type 1 diabetes. About 60 participants aged 3-45 will take the probiotic or a placebo f…
Matched conditions: TYPE1DIABETES
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Could stem cells help kids with New-Onset diabetes?
Disease control OngoingThis study tests a single infusion of stem cells from donated umbilical cord tissue (Wharton's jelly) in 66 children and teens aged 7–21 who were diagnosed with type 1 diabetes within the last 6 months. The goal is to see if the treatment is safe and can help the body produce mor…
Matched conditions: TYPE1DIABETES
Phase: PHASE1, PHASE2 • Sponsor: Uppsala University Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Probiotics may tame inflammation in new type 1 diabetes cases
Disease control OngoingThis study tests whether taking a probiotic supplement can reduce inflammation in children and teens (ages 5-17) recently diagnosed with type 1 diabetes. The goal is to see if changing gut bacteria can slow the disease's progression. Participants receive either a probiotic or a p…
Matched conditions: TYPE1DIABETES
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Could a cancer drug ease diabetes in kids with rare fat disease?
Disease control OngoingThis study tests whether cyclophosphamide, a drug that calms the immune system, can reduce insulin needs in people with a rare condition that causes fat loss (lipodystrophy) and type 1 diabetes. Ten participants will receive the treatment, and researchers will measure how much in…
Matched conditions: TYPE1DIABETES
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Donor milk vs formula: can it boost breastfeeding in fragile newborns?
Disease control OngoingThis study looks at whether giving pasteurized donor milk instead of formula to newborns at risk for low breastfeeding helps them breastfeed longer and more exclusively. About 112 infants born to diabetic mothers, small for gestational age, or late preterm are randomly assigned t…
Matched conditions: TYPE1DIABETES
Phase: NA • Sponsor: Mount Sinai Hospital, Canada • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
Low-gluten diet in toddlers may slash celiac risk, study suggests
Prevention OngoingThis study looks at whether eating very little gluten (less than 3 grams per day) during the first three years of life can lower the chance of developing celiac disease in children who are genetically at risk. Over 1,100 children with specific genes are being followed until age 7…
Matched conditions: TYPE1DIABETES
Phase: NA • Sponsor: Lund University • Aim: Prevention
Last updated Jun 08, 2026 13:05 UTC